Katalysen Ventures (KAV) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
18 Nov, 2025Executive summary
Achieved strategic milestones, including successful financing activities and portfolio expansion through the Venture Targeter model.
Strengthened partnerships and launched new revenue-generating agreements, notably with Valega Chain Analytics.
Core portfolio companies showed positive development, with QuTEM expanding in the U.S. and Invite People signing a major global client.
Improved financial results, with a 25% better period result year-over-year, driven by efficiency and revenue growth.
Enhanced investor relations with a new IR website and recurring events to engage stakeholders.
Financial highlights
Net sales for Q3 2025 were SEK 0.4 million, up from SEK 0.0 million in Q3 2024.
Group result for the period improved to -SEK 1.6 million from -SEK 2.2 million year-over-year.
Estimated portfolio value increased by 4% to SEK 141 million compared to the previous period.
Cash and cash equivalents at quarter-end were SEK 1.1 million, up from SEK 0.1 million a year earlier.
Rights issue and directed share issue raised a total of SEK 8.5 million gross.
Outlook and guidance
Several mature portfolio companies are positioned for potential exits in Q1 2026.
Continued focus on new Venture Targeter transactions to broaden the portfolio and strengthen the medium-term pipeline.
Expectation of ongoing growth in recurring revenue and further portfolio value creation.
Latest events from Katalysen Ventures
- Core investments rose 5.1%, now 75% of portfolio value; SEK 5.5M raised, debt-free.KAV
Q4 202517 Feb 2026 - Revenue up 51% YoY, portfolio value rises to SEK 135M, rights issue adds SEK 4.9M net.KAV
Q2 202519 Aug 2025 - Portfolio value dipped 2.3% as cost cuts and new investments position for future growth.KAV
Q3 202413 Jun 2025 - Portfolio value fell 8.1% but cash flow turned positive and equity increased in Q2.KAV
Q2 202413 Jun 2025 - Q1 saw a net loss from portfolio revaluations, but cost controls improved operating profit.KAV
Q1 20256 Jun 2025 - Annual loss cut by 60% as portfolio value dips 4.9% amid market headwinds.KAV
Q4 20245 Jun 2025